Digital health investor LionBird taps Pronovost as senior advisor

Pronovost serves as University Health's chief quality and clinical transformation officer.

  • LionBird backs pre-scale digital health companies
  • Firm has backed more than 30 founding teams across US and Israel since 2012
  • Firm is currently investing third fund, focused on early-stage digital health

Venture firm LionBird, which invests in digital health companies, has named Dr. Peter Pronovost as a senior advisor.

Currently, Pronovost serves as University Health’s chief quality and clinical transformation officer. He was previously senior vice president for patient safety and quality at Johns Hopkins Medicine, and founder and director of the Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality.

“For nearly two decades, it has been impossible to talk about quality, safety and value in healthcare without referencing the work of Peter Pronovost,” LionBird Partner Robert Lord said in a statement. “While we knew Dr. Pronovost by reputation, as we got to know him personally, we saw that he uniquely embodied this ideal, and had a vision for the future of healthcare in America that could inspire and inform our work.”

In his new role as senior advisor to LionBird, Pronovost will help LionBird partners to develop long-term strategy and portfolio positioning. He will also help portfolio companies directly with their strategic, commercial and operational endeavors.

LionBird, based in Tel Aviv and Evanston, Illinois, was founded in 2012 by veteran entrepreneurs and Fortune 100 executives in the software and healthcare industries. Since its inception, the firm has invested in more than 30 founding teams across the US and Israel. The firm is currently investing its third fund, which is exclusively focused on early-stage digital health.